Recent Episodes
What’s New in the Treatment of BPDCN?
Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
Mastocytosis: Insight into a Rare Blood Cancer
Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA
The Role of Genomics in Treating Blood Cancers
Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ
Insights into Pediatric Survivorship for the HCP
Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC
PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia
Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY
The Role of the Primary Care Physician in Treating Chronic Blood Cancers: Focus on Myeloma
Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ
Categories
- All Episodes (84)
- CAR T-cell Therapy (10)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (26)
- Genomics (3)
- Health Equity (6)
- Leukemia (19)
- Lymphoma (10)
- Minimal Residual Disease (MRD) (3)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (10)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)
